- Capsiate
-
- $189.00 / 5mg
-
2025-06-17
- CAS:205687-01-0
- Min. Order:
- Purity: 99.24%
- Supply Ability: 10g
- Capsite
-
- $8500.00 / 1g
-
2024-07-07
- CAS:205687-01-0
- Min. Order: 1g
- Purity: 97
- Supply Ability: 500 Kg
- CAPSIATE
-
- $6.60 / 1KG
-
2019-12-26
- CAS:205687-01-0
- Min. Order: 500g
- Purity: 98%
- Supply Ability: 1kg, 50kg, 100kg
|
| | CAPSIATE Basic information |
| Product Name: | CAPSIATE | | Synonyms: | CAPSIATE;(E)-8-Methyl-6-nonenoic acid (4-hydroxy-3-methoxyphenyl)methyl ester;CH-19 Capsiate;(4-hydroxy-3-methoxyphenyl)methyl (E)-8-methylnon-6-enoate;6-Nonenoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester, (6E)-;Natural capsiate;(E)-4-Hydroxy-3-methoxybenzyl 8-methylnon-6-enoate;Capsiate Natura | | CAS: | 205687-01-0 | | MF: | C18H26O4 | | MW: | 306.4 | | EINECS: | | | Product Categories: | | | Mol File: | 205687-01-0.mol |  |
| | CAPSIATE Chemical Properties |
| Boiling point | 421.3±40.0 °C(Predicted) | | density | 1.053 | | storage temp. | -20°C | | solubility | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml | | form | A liquid | | pka | 9.51±0.20(Predicted) | | color | Colorless to light yellow | | LogP | 4.515 (est) |
| | CAPSIATE Usage And Synthesis |
| Uses | Capsiate is a capsinoid compound which are non-pungent capsaicin analogs that can promote metabolic health and exercise tolerance. | | Definition | ChEBI: Capsiate is a carboxylic ester obtained by formal condensation of the carboxy group of (6E)-8-methylnon-6-enoic acid with the benzylic hydroxy group of vanillyl alcohol. A non-pungent analogue of capsaicin with a similar biological profile. It has a role as a plant metabolite, a hypoglycemic agent, an anti-allergic agent, an antioxidant, an angiogenesis inhibitor, an anti-inflammatory agent and a capsaicin receptor agonist. It is a carboxylic ester, a monomethoxybenzene and a member of phenols. It is functionally related to a vanillyl alcohol. | | in vivo | Capsiate does not exhibit irritancy-related effects on the oral cavity or eye[1].
Capsiate (0.03~0.54 mM; s.c.) induces nociceptive responses in mice[1]. | Animal Model: | Male ddY-strain mice (20–24 g) [1] | | Dosage: | 0.5 or 5 mM | | Administration: | P.o. | | Result: | Did not cause pungency-related behaviors.
|
| | IC 50 | TRPV1 |
| | CAPSIATE Preparation Products And Raw materials |
|